Related Experiment Video
Updated: Aug 19, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
Published on: June 4, 2012
Application of RNAi to cancer research and therapy
1National laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101.
Abstract:
The introduction of double-stranded RNA (dsRNA) into cells can effectively and specifically lead to the degradation of corresponding mRNAs in a gene-dependent manner, which is defined as RNA interfering (RNAi). This powerful technology has been widely employed to manipulate gene expression in mammalian and human cells, elucidate signal pathways and identify gene functions in a whole-genome scale. Simultaneously, many pharmaceutical companies are very interested in the research and development of RNAi-based drugs for various diseases, especially in cancers. In present review, we attempt to recapitulate the potential application of this breakthrough technology in many aspects of cancer gene therapy such as genome-scale screens, target identification and validation, functional analysis and animal models for diverse diseases.
Insights
RNA interference (RNAi) uses double-stranded RNA (dsRNA) to degrade specific messenger RNAs (mRNAs), offering a powerful tool for gene therapy. This review explores RNAi
Area of Science:
- Molecular Biology
- Gene Therapy
- Cancer Research
Background:
- RNA interference (RNAi) is a natural biological process where double-stranded RNA (dsRNA) directs the degradation of specific messenger RNAs (mRNAs).
- This gene-silencing mechanism is highly specific and can be harnessed to control gene expression.
- RNAi technology has become a valuable tool in biological research for gene function elucidation and pathway analysis.
Purpose of the Study:
- To review the diverse applications of RNA interference in cancer gene therapy.
- To highlight the potential of RNAi for genome-scale screens, target identification, and validation in cancer research.
- To discuss the utility of RNAi in functional analysis and the development of animal models for various diseases.
Main Methods:
- Review of existing literature on RNA interference technology and its applications.
- Analysis of studies employing RNAi for gene manipulation in mammalian and human cells.
- Examination of research focused on RNAi-based drug development for cancer and other diseases.
Main Results:
- RNAi enables precise manipulation of gene expression, facilitating target identification and validation.
- The technology is instrumental in performing whole-genome screens to uncover gene functions.
- RNAi has shown significant promise in preclinical studies for cancer gene therapy and disease modeling.
Conclusions:
- RNA interference represents a breakthrough technology with vast potential in cancer gene therapy.
- Its applications span from fundamental research to the development of novel therapeutic strategies.
- Further research and development are crucial for translating RNAi's potential into clinical benefits for various diseases.
More Related Videos
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Related Concept Videos
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
lncRNA - Long Non-coding RNAs
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...